HMHymn Mach

Hymn Mach

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hymn Mach has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Alison Hamilton

    Department of Pathology and Laboratory Medicine, University of Ottawa Ottawa, ON, Canada

    1 shared publication
  • Ayse E. Yilbas

    Department of Cellular and Molecular Medicine, University of Ottawa Ottawa, ON, Canada

    1 shared publication
  • Darryl Raymond Davis

    Division of Cardiology, Department of Medicine, University of Ottawa and University of Ottawa Heart Institute , H-1285D, 40 Ruskin St. Ottawa, Ottawa Ontario K1Y 4W7

    1 shared publication
  • Jihong Chen

    Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

    1 shared publication
  • Natascha Lacroix

    Department of Cellular and Molecular Medicine, University of Ottawa Ottawa, ON, Canada

    1 shared publication
  • Qiao Li

    Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada

    1 shared publication

Latest Publications

  • Open Access

    Activation of GATA4 gene expression at the early stage of cardiac specification

    by Ayse E. Yilbas, Alison Hamilton, Yingjian Wang, Hymn Mach, Natascha Lacroix, Darryl R. Davis, Jihong Chen, Qiao Li

    Currently, there are no effective treatments to directly repair damaged heart tissue after cardiac injury since existing therapies focus on rescuing or preserving reversibly damaged tissue. Cell-based therapies using cardiomyocytes generated from stem cells present a promising therapeutic approach to directly replace damaged myocardium with new healthy tissue. However, the molecular mechanisms underlying the commitment of stem cells into cardiomyocytes are not fully understood and will be critical to guide this new technology into the clinic. Since GATA4 is a critical regulator of cardiac differentiation, we examined the molecular basis underlying the early activation of GATA4 gene expression during cardiac differentiation of pluripotent stem cells. Our studies demonstrate the direct involvement of histone acetylation and transcriptional coactivator p300 in the regulation of GATA4 gene expression. More importantly, we show that histone acetyltransferase (HAT) activity is important for GATA4 gene expression with the use of curcumin, a HAT inhibitor. In addition, the widely used histone deacetylase inhibitor valproic acid enhances both histone acetylation and cardiac specification.